About Us
Company Overview
Vision / Mission / Values
Leadership
Clinical Advisory Board
Partnering
Our Approach
Technologies
Manufacturing
Publications
Pipeline
Pipeline
Autologous CAR-T
Allogeneic CAR-T
Expanded Access
Investors
Announcements
Corporate Governance
Corporate Deck & Presentations
Webcasts
Presentations
Financial Reports
Listing Documents
IR Contact
Newsroom
Careers
Join Us
Contact Us
EN
简
About Us
Company Overview
Vision / Mission / Values
Leadership
Clinical Advisory Board
Partnering
Our Approach
Technologies
Manufacturing
Publications
Pipeline
Pipeline
Autologous CAR-T
Allogeneic CAR-T
Expanded Access
Investors
Announcements
Corporate Governance
Corporate Deck & Presentations
Webcasts
Presentations
Financial Reports
Listing Documents
IR Contact
Newsroom
Careers
Join Us
Contact Us
Newsroom
Home
-
Newsroom
-
Search News
23
Jun 2017
CARsgen Therapeutics Presented at the 2017 BIO International Convention
Jun 23, 2017
05
Jun 2017
CARsgen Presents Phase I Results of CAR-GPC3 T HCC Trial at ASCO 2017 Annual Meeting
Jun 05, 2017
03
May 2017
CARsgen Therapeutics Opens CAR T-cell Manufacturing Facility in Shanghai
May 03, 2017
29
Sep 2015
CARsgen Enters into Partnership Agreement with Shanghai Cancer Institute to Develop Novel CAR-T Technology
Sep 29, 2015
26
Nov 2014
CARsgen Completes Series A Financing
Nov 26, 2014
CARsgen Therapeutics Completes $30 Million Series B Financing
Jan 05, 2023
CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion
Jan 05, 2023
1
...
9
10